CH667590A5 - Composizione farmaceutica effervescente idrosolubile contenente n-acetil-cisteina. . - Google Patents
Composizione farmaceutica effervescente idrosolubile contenente n-acetil-cisteina. . Download PDFInfo
- Publication number
- CH667590A5 CH667590A5 CH2975/86A CH297586A CH667590A5 CH 667590 A5 CH667590 A5 CH 667590A5 CH 2975/86 A CH2975/86 A CH 2975/86A CH 297586 A CH297586 A CH 297586A CH 667590 A5 CH667590 A5 CH 667590A5
- Authority
- CH
- Switzerland
- Prior art keywords
- weight
- pharmaceutical composition
- acetyl
- composition according
- citric acid
- Prior art date
Links
- 239000008194 pharmaceutical composition Substances 0.000 title claims 9
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 claims description 33
- PWKSKIMOESPYIA-BYPYZUCNSA-N L-N-acetyl-Cysteine Chemical compound CC(=O)N[C@@H](CS)C(O)=O PWKSKIMOESPYIA-BYPYZUCNSA-N 0.000 claims description 23
- 239000008187 granular material Substances 0.000 claims description 11
- 108010011485 Aspartame Proteins 0.000 claims description 9
- 239000000605 aspartame Substances 0.000 claims description 9
- IAOZJIPTCAWIRG-QWRGUYRKSA-N aspartame Chemical compound OC(=O)C[C@H](N)C(=O)N[C@H](C(=O)OC)CC1=CC=CC=C1 IAOZJIPTCAWIRG-QWRGUYRKSA-N 0.000 claims description 9
- 229960003438 aspartame Drugs 0.000 claims description 9
- 235000010357 aspartame Nutrition 0.000 claims description 9
- 239000007938 effervescent tablet Substances 0.000 claims description 8
- 229960004308 acetylcysteine Drugs 0.000 claims description 7
- 229910000030 sodium bicarbonate Inorganic materials 0.000 claims description 4
- 239000000203 mixture Substances 0.000 description 14
- UIIMBOGNXHQVGW-UHFFFAOYSA-M Sodium bicarbonate Chemical compound [Na+].OC([O-])=O UIIMBOGNXHQVGW-UHFFFAOYSA-M 0.000 description 6
- 235000003599 food sweetener Nutrition 0.000 description 6
- 239000003765 sweetening agent Substances 0.000 description 6
- 229930006000 Sucrose Natural products 0.000 description 5
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 5
- 238000000034 method Methods 0.000 description 5
- 239000005720 sucrose Substances 0.000 description 5
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 5
- 239000000975 dye Substances 0.000 description 4
- 239000000796 flavoring agent Substances 0.000 description 4
- 235000019634 flavors Nutrition 0.000 description 4
- 235000005979 Citrus limon Nutrition 0.000 description 3
- 239000007864 aqueous solution Substances 0.000 description 3
- 239000003814 drug Substances 0.000 description 3
- 229940079593 drug Drugs 0.000 description 3
- 235000017557 sodium bicarbonate Nutrition 0.000 description 3
- 239000003826 tablet Substances 0.000 description 3
- 244000248349 Citrus limon Species 0.000 description 2
- 235000019568 aromas Nutrition 0.000 description 2
- OENHQHLEOONYIE-UKMVMLAPSA-N beta-Carotene Chemical compound CC=1CCCC(C)(C)C=1/C=C/C(/C)=C/C=C/C(/C)=C/C=C/C=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C OENHQHLEOONYIE-UKMVMLAPSA-N 0.000 description 2
- 230000001013 cariogenic effect Effects 0.000 description 2
- 230000000510 mucolytic effect Effects 0.000 description 2
- 238000004806 packaging method and process Methods 0.000 description 2
- 229920000573 polyethylene Polymers 0.000 description 2
- 238000002360 preparation method Methods 0.000 description 2
- 239000000243 solution Substances 0.000 description 2
- BVKZGUZCCUSVTD-UHFFFAOYSA-M Bicarbonate Chemical compound OC([O-])=O BVKZGUZCCUSVTD-UHFFFAOYSA-M 0.000 description 1
- 244000131522 Citrus pyriformis Species 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 239000008122 artificial sweetener Substances 0.000 description 1
- 235000021311 artificial sweeteners Nutrition 0.000 description 1
- TUPZEYHYWIEDIH-WAIFQNFQSA-N beta-carotene Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1=C(C)CCCC1(C)C)C=CC=C(/C)C=CC2=CCCCC2(C)C TUPZEYHYWIEDIH-WAIFQNFQSA-N 0.000 description 1
- 235000013734 beta-carotene Nutrition 0.000 description 1
- 239000011648 beta-carotene Substances 0.000 description 1
- 229960002747 betacarotene Drugs 0.000 description 1
- 206010012601 diabetes mellitus Diseases 0.000 description 1
- 238000001035 drying Methods 0.000 description 1
- 230000002349 favourable effect Effects 0.000 description 1
- 239000008368 mint flavor Substances 0.000 description 1
- 239000001048 orange dye Substances 0.000 description 1
- 235000019629 palatability Nutrition 0.000 description 1
- 239000000825 pharmaceutical preparation Substances 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 238000005303 weighing Methods 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0002—Galenical forms characterised by the drug release technique; Application systems commanded by energy
- A61K9/0007—Effervescent
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Medicinal Preparation (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Priority Applications (8)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CH2975/86A CH667590A5 (it) | 1986-07-24 | 1986-07-24 | Composizione farmaceutica effervescente idrosolubile contenente n-acetil-cisteina. . |
DE19873723735 DE3723735A1 (de) | 1986-07-24 | 1987-07-17 | Pharmazeutische, n-acetylcystein enthaltende, wasserloesliche zusammensetzung |
FR878710368A FR2601876B1 (fr) | 1986-07-24 | 1987-07-22 | Composition pharmaceutique hydrosoluble contenant de la n-acetyl-cysteine et de l'acide citrique |
IT21411/87A IT1222104B (it) | 1986-07-24 | 1987-07-23 | Composizione farmaceutica idrosolubile contenente n acetilsisteina |
NL8701743A NL194067C (nl) | 1986-07-24 | 1987-07-23 | Farmaceutisch wateroplosbaar bruispreparaat dat N-acetylcysteine en aspartame bevat. |
BE8700816A BE1000355A3 (fr) | 1986-07-24 | 1987-07-23 | Composition pharmaceutique hydrosoluble contenant de la n-acetyl-cysteine et de l'acide citrique. |
SE8702940A SE500494C2 (sv) | 1986-07-24 | 1987-07-23 | Farmaceutisk, vattenlöslig komposition, innehållande N-acetyl-cystein och aspartam |
GB8717582A GB2192790B (en) | 1986-07-24 | 1987-07-27 | Effervescent n-acetyl cysteine compositions. |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CH2975/86A CH667590A5 (it) | 1986-07-24 | 1986-07-24 | Composizione farmaceutica effervescente idrosolubile contenente n-acetil-cisteina. . |
Publications (1)
Publication Number | Publication Date |
---|---|
CH667590A5 true CH667590A5 (it) | 1988-10-31 |
Family
ID=4245841
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CH2975/86A CH667590A5 (it) | 1986-07-24 | 1986-07-24 | Composizione farmaceutica effervescente idrosolubile contenente n-acetil-cisteina. . |
Country Status (8)
Country | Link |
---|---|
BE (1) | BE1000355A3 (sv) |
CH (1) | CH667590A5 (sv) |
DE (1) | DE3723735A1 (sv) |
FR (1) | FR2601876B1 (sv) |
GB (1) | GB2192790B (sv) |
IT (1) | IT1222104B (sv) |
NL (1) | NL194067C (sv) |
SE (1) | SE500494C2 (sv) |
Families Citing this family (28)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
IT1217445B (it) * | 1988-04-29 | 1990-03-22 | Altergon Sa | Composizione farmaceutiche orosolubili contenti acetilcisteina |
DE3822096A1 (de) * | 1988-06-30 | 1990-01-04 | Klinge Co Chem Pharm Fab | Stabilisierte arzneimittelzubereitung |
SE462779B (sv) * | 1988-10-10 | 1990-09-03 | Lejus Medical Ab | Farmaceutisk komposition innehaallande n-acetylcystein i en kaerna belagd med hydroxipropylmetylcellulosaftalat |
DE3909049A1 (de) * | 1989-03-18 | 1990-09-20 | Arthur Boskamp | Praeparat und dessen verwendung |
IT1231012B (it) * | 1989-07-27 | 1991-11-08 | Zambon Spa | Composizione farmaceutica per uso orale contenente nac. |
DK0497724T3 (da) * | 1991-01-26 | 1996-04-29 | Senju Pharma Co | Middel til desintegration af galdesten |
DE4103360A1 (de) * | 1991-02-05 | 1992-08-06 | Koehler Peter | Medikament zur linderung und heilung von asthma bronchiale und anderen lungenerkrankungen |
US5296500A (en) * | 1991-08-30 | 1994-03-22 | The Procter & Gamble Company | Use of N-acetyl-cysteine and derivatives for regulating skin wrinkles and/or skin atrophy |
IT1256616B (it) * | 1992-12-02 | 1995-12-12 | Zambon Spa | Sciroppo contenente n-acetil-cisteina |
DE4406261C2 (de) * | 1993-08-31 | 1996-07-04 | Deutsches Krebsforsch | Verwendung von Thiolverbindungen zur Verminderung der Körperfettmenge |
BE1007926A3 (fr) * | 1994-01-31 | 1995-11-21 | Zambon Int Pharma | Composition pharmaceutique contenant de la n-acetyl-cysteine. |
US5451405A (en) * | 1994-04-25 | 1995-09-19 | Chesebrough-Pond's Usa Co. | Skin treatment composition |
DE19509856C2 (de) * | 1995-03-17 | 1997-09-11 | Schwabe Willmar Gmbh & Co | Verwendung einer Brausezusammensetzung mit Ginkgo-Biloba Trockenextrakt zur Behandlung peripherer und cerebraler Durchblutungsstörungen |
WO2000018392A1 (en) | 1998-09-25 | 2000-04-06 | Glycox Corporation Limited | Fructosamine oxidase: antagonists and inhibitors |
AU772616B2 (en) | 1998-09-25 | 2004-05-06 | Protemix Corporation Limited | Fructosamine oxidase assay: methods and materials |
AU2003225442B2 (en) | 2002-03-08 | 2010-02-04 | Philera New Zealand Limited | Preventing and/or treating cardiovascular disease and/or associated heart failure |
EP1539129A4 (en) | 2002-08-20 | 2006-03-08 | Protemix Corp Ltd | DOSAGE FORMS AND RELEVANT THERAPIES |
PT1778618E (pt) | 2004-07-19 | 2014-03-04 | Philera New Zealand Ltd | Síntese de trietilenotetraminas |
TR200900881A2 (tr) * | 2009-02-05 | 2010-08-23 | Bi̇lgi̇ç Mahmut | Tadı ve kokusu maskelenmiş stabil farmasötik bileşimler |
TR200900882A2 (tr) * | 2009-02-05 | 2010-08-23 | Bi̇lgi̇ç Mahmut | Tadı ve kokusu maskelenmiş, bıyoyararlanımı yüksek farmasotık bileşimler. |
IT1399492B1 (it) * | 2010-04-13 | 2013-04-19 | Alpex Pharma Sa | Composizioni farmaceutiche effervescenti contenenti n-acetilcisteina. |
CN102233139B (zh) * | 2010-04-21 | 2012-09-05 | 重庆健能医药开发有限公司 | 一种乙酰半胱氨酸泡腾片及其制备方法和应用 |
WO2011146031A1 (en) * | 2010-05-18 | 2011-11-24 | Bilgic Mahmut | Pharmaceutical composition comprising n- acetylcysteine and a xanthine |
CN101947211A (zh) * | 2010-08-28 | 2011-01-19 | 浙江金华康恩贝生物制药有限公司 | 一种乙酰半胱氨酸泡腾片的制备方法 |
TR201104738A2 (tr) * | 2011-05-16 | 2012-12-21 | Bi̇lgi̇ç Mahmut | N-Asetilsistein içeren farmasötik kombinasyon. |
US8747894B2 (en) * | 2012-05-08 | 2014-06-10 | Alpex Pharma S.A. | Effervescent compositions containing N-acetylcysteine |
WO2015117987A1 (en) * | 2014-02-05 | 2015-08-13 | Sanovel Ilac Sanayi Ve Ticaret A.S. | Effervescent formulations comprising ibuprofen and n-acetylcystein |
CN113559078A (zh) * | 2021-07-02 | 2021-10-29 | 安徽省先锋制药有限公司 | 一种乙酰半胱氨酸泡腾片的制备方法 |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2470M (fr) * | 1962-03-13 | 1964-04-20 | Mead Johnson & Co | Composition thérapeutique. |
ZA723683B (en) * | 1971-07-12 | 1973-06-27 | Hoffmann La Roche | Improved effervescent preparations |
DE3317558A1 (de) * | 1983-05-13 | 1984-11-15 | Dietrich Dr.med. Sta. Eulalia Ibiza Reichert | Orales antischnarchmittel |
DE3317530A1 (de) * | 1983-05-13 | 1984-11-15 | Dietrich Dr.med. Sta. Eulalia Ibiza Reichert | Antischnarchmittel |
IT1170268B (it) * | 1983-12-21 | 1987-06-03 | Zambon Spa | Uso dell'acetilcisteina per ridurre l'incremento della prolieferazione delle cellule basali dell'epitelio respiratoriotracheo-bronchiale indotto dal fumo di tabacco nei mammiferi |
DE3514995A1 (de) * | 1985-04-25 | 1986-10-30 | Protopharma Ltd., 7831 Malterdingen | Verwendung von sulfydrylarzneimitteln zur bekaempfung von schaedigungen der magenschleimhaut |
-
1986
- 1986-07-24 CH CH2975/86A patent/CH667590A5/it not_active IP Right Cessation
-
1987
- 1987-07-17 DE DE19873723735 patent/DE3723735A1/de active Granted
- 1987-07-22 FR FR878710368A patent/FR2601876B1/fr not_active Expired
- 1987-07-23 SE SE8702940A patent/SE500494C2/sv not_active IP Right Cessation
- 1987-07-23 BE BE8700816A patent/BE1000355A3/fr not_active IP Right Cessation
- 1987-07-23 IT IT21411/87A patent/IT1222104B/it active
- 1987-07-23 NL NL8701743A patent/NL194067C/nl not_active IP Right Cessation
- 1987-07-27 GB GB8717582A patent/GB2192790B/en not_active Expired - Lifetime
Also Published As
Publication number | Publication date |
---|---|
FR2601876B1 (fr) | 1989-10-13 |
NL8701743A (nl) | 1988-02-16 |
SE8702940L (sv) | 1988-01-25 |
IT1222104B (it) | 1990-08-31 |
DE3723735C2 (sv) | 1992-05-21 |
NL194067B (nl) | 2001-02-01 |
NL194067C (nl) | 2001-06-05 |
GB2192790B (en) | 1990-01-31 |
DE3723735A1 (de) | 1988-02-04 |
SE500494C2 (sv) | 1994-07-04 |
BE1000355A3 (fr) | 1988-11-08 |
SE8702940D0 (sv) | 1987-07-23 |
FR2601876A1 (fr) | 1988-01-29 |
GB8717582D0 (en) | 1987-09-03 |
GB2192790A (en) | 1988-01-27 |
IT8721411A0 (it) | 1987-07-23 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CH667590A5 (it) | Composizione farmaceutica effervescente idrosolubile contenente n-acetil-cisteina. . | |
ES2263216T3 (es) | Procedimiento para la preparacion de un granulado adecuado para la preparacion de comprimidos solubles en la boca rapidamente disgregables. | |
CH666814A5 (it) | Composizione farmaceutica idrosolubile contenente n-acetil-cisteina. | |
AU613517B2 (en) | Morphine-containing composition | |
US4760094A (en) | Spray dried acetaminophen | |
AU627194B2 (en) | Pharmaceutical compositions | |
US20030161879A1 (en) | Tablets quickly disintegrating in mouth | |
CH689249A5 (it) | Composizioni farmaceutiche a base di gomma da masticare e procedimento per la loro preparazione. | |
BG65011B1 (bg) | Усъвършенствани бързоразпадащи се таблетки | |
HUP0402154A2 (hu) | Metformint és glibenklamidot tartalmazó gyógyászati készítmény II-es típusú diabetes mellitus kezelésére | |
ES2365648T3 (es) | Administración oral de una calcitonina. | |
CA2450359A1 (en) | Dosage regimen and pharmaceutical composition for emergency contraception | |
HUP0301390A2 (hu) | Valzartánt tartalmazó orális gyógyászati készítmény | |
US2714083A (en) | Appetite satient | |
KR100441179B1 (ko) | 디클로페낙계제약학적조성물 | |
AU637773B2 (en) | Fruity flavoured nasal decongestant composition | |
JPS5982311A (ja) | セフアレキシン持効性製剤 | |
MX2011002400A (es) | Preparacion farmaceutica solida que tiene ingredientes activos separados por limites en la misma. | |
SI21221A (sl) | Hitro razpadljive tablete | |
US7182964B2 (en) | Dissolving thin film xanthone supplement | |
CA2521272A1 (en) | Capsules comprising topiramate | |
US5006516A (en) | Method for the prophylaxis of cardiac infarctions and the prevention of reinfarctions | |
US20080152677A1 (en) | Oral hygiene formulations in the form of capsules | |
UA79567C2 (en) | Orodispersible pharmaceutical composition of antithrombolic compound | |
CA2362757A1 (en) | Effervescent pharmaceutical formulation containing metamizole |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
NV | New agent |
Representative=s name: E. BLUM & CO. PATENTANWAELTE |
|
PUE | Assignment |
Owner name: INPHARZAM INTERNATIONAL S.A. TRANSFER- INPHARZAM S |
|
PL | Patent ceased |